Conduit Pharmaceuticals Stock Technical Analysis
| CDT Stock | 1.08 0.04 3.85% |
As of the 15th of February 2026, Conduit Pharmaceuticals shows the Standard Deviation of 7.26, mean deviation of 5.23, and Risk Adjusted Performance of (0.11). Conduit Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Conduit Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Conduit, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ConduitConduit Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is there potential for Life Sciences Tools & Services market expansion? Will Conduit introduce new products? Factors like these will boost the valuation of Conduit Pharmaceuticals. Projected growth potential of Conduit fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Conduit Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Conduit Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Conduit's accounting equity. The concept of intrinsic value - what Conduit Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Conduit Pharmaceuticals' price substantially above or below its fundamental value.
It's important to distinguish between Conduit Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Conduit Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Conduit Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Conduit Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Conduit Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Conduit Pharmaceuticals.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Conduit Pharmaceuticals on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Conduit Pharmaceuticals or generate 0.0% return on investment in Conduit Pharmaceuticals over 90 days. Conduit Pharmaceuticals is related to or competes with Longevity Health, ZyVersa Therapeutics, Envoy Medical, Scworx Corp, Lixte Biotechnology, NewGenIvf Group, and Concord Medical. Conduit Pharmaceuticals is entity of United States More
Conduit Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Conduit Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Conduit Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 40.12 | |||
| Value At Risk | (13.57) | |||
| Potential Upside | 12.43 |
Conduit Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Conduit Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Conduit Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Conduit Pharmaceuticals historical prices to predict the future Conduit Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.26) | |||
| Total Risk Alpha | (1.64) | |||
| Treynor Ratio | (0.39) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Conduit Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Conduit Pharmaceuticals February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.38) | |||
| Mean Deviation | 5.23 | |||
| Coefficient Of Variation | (669.28) | |||
| Standard Deviation | 7.26 | |||
| Variance | 52.77 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.26) | |||
| Total Risk Alpha | (1.64) | |||
| Treynor Ratio | (0.39) | |||
| Maximum Drawdown | 40.12 | |||
| Value At Risk | (13.57) | |||
| Potential Upside | 12.43 | |||
| Skewness | (0.01) | |||
| Kurtosis | 1.23 |
Conduit Pharmaceuticals Backtested Returns
Conduit Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Conduit Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Conduit Pharmaceuticals' Mean Deviation of 5.23, standard deviation of 7.26, and Risk Adjusted Performance of (0.11) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.79, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Conduit Pharmaceuticals will likely underperform. At this point, Conduit Pharmaceuticals has a negative expected return of -0.86%. Please make sure to confirm Conduit Pharmaceuticals' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Conduit Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
Conduit Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Conduit Pharmaceuticals time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Conduit Pharmaceuticals price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Conduit Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Conduit Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Conduit Pharmaceuticals Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Conduit Pharmaceuticals across different markets.
About Conduit Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Conduit Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Conduit Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Conduit Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Conduit Pharmaceuticals. By analyzing Conduit Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Conduit Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Conduit Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | Dividend Yield | 0.16 | 0.14 | 0.13 | Price To Sales Ratio | 0.0187 | 0.0168 | 0.015 |
Conduit Pharmaceuticals February 15, 2026 Technical Indicators
Most technical analysis of Conduit help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Conduit from various momentum indicators to cycle indicators. When you analyze Conduit charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.38) | |||
| Mean Deviation | 5.23 | |||
| Coefficient Of Variation | (669.28) | |||
| Standard Deviation | 7.26 | |||
| Variance | 52.77 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.26) | |||
| Total Risk Alpha | (1.64) | |||
| Treynor Ratio | (0.39) | |||
| Maximum Drawdown | 40.12 | |||
| Value At Risk | (13.57) | |||
| Potential Upside | 12.43 | |||
| Skewness | (0.01) | |||
| Kurtosis | 1.23 |
Conduit Pharmaceuticals February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Conduit stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | 0.57 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 1.07 | ||
| Day Typical Price | 1.07 | ||
| Price Action Indicator | 0.04 | ||
| Market Facilitation Index | 0.07 |
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.